ASCO '12 Abstract Dump: Cancer Stocks in Focus
...study of Bayer and Onyx's regorafenib in advanced gastrointestinal stromal tumors; several Roche/Genentech(RHHBY) studies, including Avastin in ovarian cancer and TDM-1 in breast cancer (partnered with Immunogen(IMGN)); melanoma data from GlaxoSmithKline's(GSK)...










Novartis
National Health Service
AMD
United Kingdom
